(Q53361031)

13 May 2018

title

Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. (English)

1 reference

13 May 2018

1 reference

Alipov G

1

1 reference

13 May 2018

Nakayama T

2

1 reference

13 May 2018

Ito M

3

1 reference

13 May 2018

Kawai K

4

1 reference

13 May 2018

Naito S

5

1 reference

13 May 2018

Nakashima M

6

1 reference

13 May 2018

Niino D

7

1 reference

13 May 2018

Sekine I

8

1 reference

13 May 2018

publication date

1 February 2005

1 reference

13 May 2018

published in

Histopathology

1 reference

13 May 2018

volume

46

1 reference

13 May 2018

page(s)

202-208

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Oncogenic conversion of transcription factors by chromosomal translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Tripartite structure of the avian erythroblastosis virus E26 transforming gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Expression of the ets-1 proto-oncogene in human colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Histologic grading of prostate cancer: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

p53 mutations occur in clinical, but not latent, human prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Expression of c-Ets1 is associated with malignant potential in endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Oncogenic potential of bcl-2 demonstrated by gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02059.X

10.1111/J.1365-2559.2005.02059.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

15693893

1 reference

13 May 2018